Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q1 2026

InnovAge Holding Q1 2026 Results: Net Income $19.6M, Up 143.8% YoY

InnovAge Holding Corp. reported a reduction in its retained deficit from $105.8 million to $86.2 million for the quarter ended September 30, 2026, indicating a profitable period. Total assets increased slightly to $563.0 million, driven by a rise in cash and cash equivalents to $119.3 million.

Q1 2026 at a glance · $ million
MetricQ1 2026Q1 2025
Revenue264.8236.1
Net income19.68.0
EPS (diluted, $ a share)$0.14$0.06

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+143.8%
Revenue, year on year+12.1%
Operating margin7.6%
Source

10-Q filed with the SEC, NASDAQ: INNV. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

InnovAge Holding Corp.: key numbers

Share price
$9.58Close, Nov 16
Market cap
$1.31B
Shares outstanding
136.45MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Health ServicesSIC 8000

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from InnovAge Holding Corp.

All →
4:08 PM ET 8-K
Financial Results

InnovAge Holding Financial Results

InnovAge Holding Corp. reported financial results for its fiscal first quarter ended September 30, 2026, with revenue increasing 12.1% year-over-year to $264.8 million. Net income rose significantly to $20.9 million, or $0.14 per share, driven by census growth and disciplined clinical execution. The company ended the quarter with approximately 8,420 participants and $163 million in total cash and short-term investments.

Term
Q1 2027

“We are pleased with our strong stat to fiscal 2027, as continued census growth along with disciplined clinical and operational execution drove strong financial performance. Our first quarter results reinforce the progress we have made over the past serval years and our confidence in the long-term potential of the business.”

Patrick Blair, Chief Executive Officer of InnovAge
4:03 PM ET Form 4
Insider Selling

InnovAge Holding CLO Nicole Damato Sells $32.4K of Stock

Nicole Damato, CLO, sold 3,402 shares of InnovAge Holding Corp. at $9.51 a share, worth $32.4K in total on Oct 22, 2026. Shares held after the trade: 301,495 (-1.1%).

Value
$32.4K
Shares
3,402
Price
$9.51
Role
CLO
Holding change
-1.1%
Trade date
Oct 22, 2026
4:31 PM ET Form 4
Insider Selling

InnovAge Holding 10% Owner Welsh Carson Anderson & Stowe XII L.P. Sells $13.9M of Stock

Welsh Carson Anderson & Stowe XII L.P., 10% Owner, sold 1,500,000 shares of InnovAge Holding Corp. at $9.25 a share, worth $13.9M in total on Oct 21, 2026. Shares held after the trade: 101,076,555 (-1.5%).

Value
$13.9M
Shares
1,500,000
Price
$9.25
Role
10% Owner
Holding change
-1.5%
Trade date
Oct 21, 2026
4:06 PM ET Form 4
Insider Selling

InnovAge Holding 10% Owner Ignite Aggregator LP Sells $13.9M of Stock

Ignite Aggregator LP, 10% Owner, sold 1,500,000 shares of InnovAge Holding Corp. at $9.25 a share, worth $13.9M in total on Oct 21, 2026. Shares held after the trade: 101,076,555 (-1.5%).

Value
$13.9M
Shares
1,500,000
Price
$9.25
Role
10% Owner
Holding change
-1.5%
Trade date
Oct 21, 2026
4:05 PM ET Form 4
Insider Selling

InnovAge Holding 10% Owner Tco Group Holdings L.P. Sells $13.9M of Stock

Tco Group Holdings L.P., 10% Owner, sold 1,500,000 shares of InnovAge Holding Corp. at $9.25 a share, worth $13.9M in total on Oct 21, 2026. Shares held after the trade: 101,076,555 (-1.5%).

Value
$13.9M
Shares
1,500,000
Price
$9.25
Role
10% Owner
Holding change
-1.5%
Trade date
Oct 21, 2026
4:02 PM ET 8-K
M&A Deal

InnovAge Holding Signs $92.5M M&A Deal with Barclays Capital Inc.

InnovAge Holding Corp. announced the closing of a secondary offering of 10,000,000 shares of common stock by a selling shareholder at a price of $9.25 per share. The company did not receive any proceeds from the sale, as the shares were previously issued and held by the selling stockholder. The underwriters were also granted a 30-day option to purchase up to an additional 1,500,000 shares.

Value
$92.5M
Counterparty
Barclays Capital Inc., Goldman Sachs & Co. LLC and Wells Fargo Securities, LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.